vs

Side-by-side financial comparison of Dynatrace, Inc. (DT) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

Dynatrace, Inc. is the larger business by last-quarter revenue ($515.5M vs $510.9M, roughly 1.0× Genius Sports Ltd). Dynatrace, Inc. runs the higher net margin — 7.8% vs -12.3%, a 20.1% gap on every dollar of revenue. Genius Sports Ltd produced more free cash flow last quarter ($69.6M vs $27.2M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 16.3%).

Dynatrace, Inc. is an American multinational technology company that provides an AI-powered observability platform. Their software is used to monitor, analyze, and optimize application performance, software development, cyber security practices, IT infrastructure, and user experience.

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

DT vs GENI — Head-to-Head

Bigger by revenue
DT
DT
1.0× larger
DT
$515.5M
$510.9M
GENI
Higher net margin
DT
DT
20.1% more per $
DT
7.8%
-12.3%
GENI
More free cash flow
GENI
GENI
$42.3M more FCF
GENI
$69.6M
$27.2M
DT
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
16.3%
DT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
DT
DT
GENI
GENI
Revenue
$515.5M
$510.9M
Net Profit
$40.1M
$-63.0M
Gross Margin
81.4%
25.2%
Operating Margin
14.1%
-11.5%
Net Margin
7.8%
-12.3%
Revenue YoY
18.2%
Net Profit YoY
-88.9%
EPS (diluted)
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DT
DT
GENI
GENI
Q4 25
$515.5M
$510.9M
Q3 25
$493.8M
$335.4M
Q2 25
$477.3M
$215.2M
Q1 25
$445.2M
$119.7M
Q4 24
$436.2M
$413.0M
Q3 24
$418.1M
$285.8M
Q2 24
$399.2M
$184.1M
Q1 24
$380.8M
$97.2M
Net Profit
DT
DT
GENI
GENI
Q4 25
$40.1M
$-63.0M
Q3 25
$57.2M
Q2 25
$48.0M
$-47.3M
Q1 25
$39.3M
$-25.5M
Q4 24
$361.8M
$-85.5M
Q3 24
$44.0M
$-47.1M
Q2 24
$38.6M
$-35.5M
Q1 24
$37.9M
$-25.2M
Gross Margin
DT
DT
GENI
GENI
Q4 25
81.4%
25.2%
Q3 25
81.8%
24.2%
Q2 25
82.1%
19.1%
Q1 25
80.9%
10.7%
Q4 24
81.1%
16.7%
Q3 24
81.4%
20.5%
Q2 24
81.3%
18.6%
Q1 24
81.1%
9.8%
Operating Margin
DT
DT
GENI
GENI
Q4 25
14.1%
-11.5%
Q3 25
14.8%
-15.3%
Q2 25
13.1%
-21.0%
Q1 25
9.6%
-20.3%
Q4 24
10.9%
-18.0%
Q3 24
11.2%
-13.9%
Q2 24
10.5%
-16.8%
Q1 24
6.1%
-23.7%
Net Margin
DT
DT
GENI
GENI
Q4 25
7.8%
-12.3%
Q3 25
11.6%
Q2 25
10.0%
-22.0%
Q1 25
8.8%
-21.3%
Q4 24
82.9%
-20.7%
Q3 24
10.5%
-16.5%
Q2 24
9.7%
-19.3%
Q1 24
10.0%
-25.9%
EPS (diluted)
DT
DT
GENI
GENI
Q4 25
$0.13
Q3 25
$0.19
Q2 25
$0.16
Q1 25
$0.12
Q4 24
$1.19
Q3 24
$0.15
Q2 24
$0.13
Q1 24
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DT
DT
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$1.2B
$280.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$724.5M
Total Assets
$4.1B
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DT
DT
GENI
GENI
Q4 25
$1.2B
$280.6M
Q3 25
$1.3B
$110.2M
Q2 25
$1.3B
$110.2M
Q1 25
$1.1B
$110.2M
Q4 24
$1.0B
$100.3M
Q3 24
$1.0B
$100.3M
Q2 24
$1.0B
$100.3M
Q1 24
$836.9M
$100.3M
Stockholders' Equity
DT
DT
GENI
GENI
Q4 25
$2.7B
$724.5M
Q3 25
$2.8B
$572.4M
Q2 25
$2.7B
$572.4M
Q1 25
$2.6B
$572.4M
Q4 24
$2.6B
$573.0M
Q3 24
$2.1B
$573.0M
Q2 24
$2.1B
$573.0M
Q1 24
$2.0B
$573.0M
Total Assets
DT
DT
GENI
GENI
Q4 25
$4.1B
$1.1B
Q3 25
$4.1B
$792.3M
Q2 25
$4.1B
$792.3M
Q1 25
$4.1B
$792.3M
Q4 24
$3.7B
$775.7M
Q3 24
$3.3B
$775.7M
Q2 24
$3.3B
$775.7M
Q1 24
$3.4B
$775.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DT
DT
GENI
GENI
Operating Cash FlowLast quarter
$33.8M
$81.9M
Free Cash FlowOCF − Capex
$27.2M
$69.6M
FCF MarginFCF / Revenue
5.3%
13.6%
Capex IntensityCapex / Revenue
1.3%
2.4%
Cash ConversionOCF / Net Profit
0.84×
TTM Free Cash FlowTrailing 4 quarters
$465.5M
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DT
DT
GENI
GENI
Q4 25
$33.8M
$81.9M
Q3 25
$32.0M
$-4.8M
Q2 25
$269.7M
$-1.2M
Q1 25
$162.8M
$-14.6M
Q4 24
$42.2M
$14.9M
Q3 24
$23.6M
$-9.2M
Q2 24
$230.7M
Q1 24
$131.7M
Free Cash Flow
DT
DT
GENI
GENI
Q4 25
$27.2M
$69.6M
Q3 25
$27.8M
$-14.2M
Q2 25
$262.2M
$-5.8M
Q1 25
$148.2M
$-16.0M
Q4 24
$37.6M
$11.3M
Q3 24
$20.1M
$-11.6M
Q2 24
$227.4M
Q1 24
$121.9M
FCF Margin
DT
DT
GENI
GENI
Q4 25
5.3%
13.6%
Q3 25
5.6%
-4.2%
Q2 25
54.9%
-2.7%
Q1 25
33.3%
-13.4%
Q4 24
8.6%
2.7%
Q3 24
4.8%
-4.1%
Q2 24
57.0%
Q1 24
32.0%
Capex Intensity
DT
DT
GENI
GENI
Q4 25
1.3%
2.4%
Q3 25
0.8%
2.8%
Q2 25
1.6%
2.1%
Q1 25
3.3%
1.2%
Q4 24
1.1%
0.9%
Q3 24
0.8%
0.9%
Q2 24
0.8%
Q1 24
2.6%
Cash Conversion
DT
DT
GENI
GENI
Q4 25
0.84×
Q3 25
0.56×
Q2 25
5.62×
Q1 25
4.14×
Q4 24
0.12×
Q3 24
0.54×
Q2 24
5.97×
Q1 24
3.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DT
DT

Subscription And Circulation$493.4M96%
Services$22.1M4%

GENI
GENI

Segment breakdown not available.

Related Comparisons